We are live on ! Find out more
NUVB.WS

Nuvation Bio Inc Warrants
NUVB.WS

Delisted

NUVB.WS was delisted on the 10th of February, 2026.

Back to rankings

17 hedge funds and large institutions have $1.63M invested in Nuvation Bio Inc Warrants in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $1.59M → $1.63M (+$32K)

0.08% less ownership

Funds ownership: 1.76% → 1.68% (-0.08%)

15% less funds holding

Funds holding: 20 → 17 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$224
2
Citadel Advisors
Citadel Advisors
Florida
+$24

Top Sellers

Rank Fund Capital Flow
1
CC
Clearline Capital
New York
-$3.33K
2
IP
Intellectus Partners
California
-$1.39K
3
UBS Group
UBS Group
Switzerland
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$1.45M – – –
6CM
2
683 Capital Management
New York
$50.1K – – –
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$16K – – –
BC
4
Boxer Capital
California
$16K – – –
Franklin Resources
5
Franklin Resources
California
$16K – – –
DM
6
Deerfield Management
New York
$10K – – –
HCM
7
Highbridge Capital Management
New York
$9.52K – – –
BlackRock
8
BlackRock
New York
$9.22K – – –
RSCM
9
Rock Springs Capital Management
Maryland
$8.04K – – –
SB
10
Samsara BioCapital
California
$8K – – –
GC
11
Greenlight Capital
New York
$6K – – –
ACP
12
Acuta Capital Partners
California
$5.45K – – –
APM
13
Avidity Partners Management
Texas
$5.37K – – –
Citadel Advisors
14
Citadel Advisors
Florida
$4.42K +$24 +432 +0.6%
LGM
15
Logos Global Management
California
$4K – – –
Victory Capital Management
16
Victory Capital Management
Texas
$3.67K – – –
WAM
17
Wolverine Asset Management
Illinois
$237 +$224 +3,963 New
Barclays
18
Barclays
United Kingdom
$98 – – –
CCA
19
Castle Creek Arbitrage
Colorado
– -$12.2K -135,426 Closed
CC
20
Clearline Capital
New York
– -$3.33K -33,271 Closed
IP
21
Intellectus Partners
California
– -$1.39K -13,891 Closed
UBS Group
22
UBS Group
Switzerland
– -$8 -84 Closed

NUVB.WS Hedge Fund Activity: Q4 2023 in Review

17 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q4 2023, worth a combined $1.63M — up 2% from $1.59M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NUVB.WS and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $224. The largest seller was Clearline Capital, exiting entirely with an estimated $3.33K sold.

  • 17 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q4 2023, down from 20 in Q3 2023.
  • Funds reported $1.63M of Nuvation Bio Inc Warrants stock for Q4 2023, up 2% quarter-over-quarter.
  • 1 fund opened new Nuvation Bio Inc Warrants positions in Q4 2023 and 4 closed out, a net change of -3 holders.
  • The largest Nuvation Bio Inc Warrants buyer in Q4 2023 was Wolverine Asset Management, an estimated $224 added.
  • The largest Nuvation Bio Inc Warrants seller in Q4 2023 was Clearline Capital, an estimated $3.33K sold.

Based on aggregated 13F filings for Q4 2023.